Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001209191-23-007787

Chief Medical Officer acquired 54,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Attar Eyal C. Chief Medical Officer 2023-02-06 Grant or award +54,500 54,500 D
Derivatives
Attar Eyal C. Chief Medical Officer 2023-02-06 Grant or award · Employee Stock Option (right to buy) +109,000 109,000 D
Loading xslF345X03/doc4.xml…